(09:07 GMT) Crinetics Pharmaceuticals Price Target Announced at $55.00/Share by UBS
Dow Jones Newswires
Crinetics Pharmaceuticals Initiated at Buy by UBS
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:CRNX
- Language
- English
(09:07 GMT) Crinetics Pharmaceuticals Price Target Announced at $55.00/Share by UBS